Interestin_老虎社区_美港股上老虎

sgrs
2021-12-03

Interesting

Vaccine makers should plan to adjust COVID-19 jabs - WHO

GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the "likelihood" of needing

Vaccine makers should plan to adjust COVID-19 jabs - WHO

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":601213073,"tweetId":"601213073","gmtCreate":1638533968624,"gmtModify":1638533968736,"author":{"id":3582199304143416,"idStr":"3582199304143416","authorId":3582199304143416,"authorIdStr":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Interesting</p></body></html>","htmlText":"<html><head></head><body><p>Interesting</p></body></html>","text":"Interesting","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/601213073","repostId":1177709350,"repostType":4,"repost":{"id":"1177709350","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638533783,"share":"https://www.laohu8.com/m/news/1177709350?lang=&edition=full","pubTime":"2021-12-03 20:16","market":"us","language":"en","title":"Vaccine makers should plan to adjust COVID-19 jabs - WHO","url":"https://stock-news.laohu8.com/highlight/detail?id=1177709350","media":"Reuters","summary":"GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the \"likelihood\" of needing","content":"<p>GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the \"likelihood\" of needing to adjust their products to protect against the Omicron variant, the World Health Organization's (WHO) spokesperson said on Friday.</p>\n<p>Christian Lindmeier, speaking at a U.N. briefing in Geneva, said the agency was studying the transmissibility and severity of the variant first detected in southern Africa last month.</p>\n<p>\"It is very recommendable that vaccine manufacturers already start planning ahead and plan for the likelihood for having to adjust the existing vaccine,\" he said.</p>\n<p>\"That's good not just to wait until the final alarm bell rings,\" he said.</p>\n<p>Germany's BioNTech&nbsp;should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, its CEO Ugur Sahin told the Reuters Next conference on Friday.</p>\n<p>South African scientists studying the Omicron outbreak believe symptoms are less severe for those reinfected with COVID-19 by the new variant or infected after vaccination, a top scientist said on Thursday.</p>\n<p>Maria van Kerkhove, the WHO's technical lead on COVID-19, said on Wednesday that the body expected to have more information on the transmissibility of the new Omicron variant \"within days\".</p>\n<p>\"It will still take some time and let's not rush into conclusions here,\" Lindmeier said on Friday.</p>\n<p>\"Preliminary data, and we have said that now since awhile, show that there is higher transmissibility. But that's all that we basically have so far,\" he said.</p>\n<p>Delta remains the dominant variant globally, accounting for more than 90% of infections, Lindmeier said.</p>\n<p>\"So Omicron may be on the rise, and we may come to point where it takes over to be the dominant variant, but at this point the very dominant variant remains Delta,\" he said.</p>\n<p>\"The restrictions that were put into place in many countries just two weeks ago, economic closures again, lockdowns in some areas, closure of Christmas markets in parts of Europe, this was done before Omicron because of a rise in Delta cases.</p>\n<p>Let's not lose sight of this,\" he added.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine makers should plan to adjust COVID-19 jabs - WHO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine makers should plan to adjust COVID-19 jabs - WHO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-03 20:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the \"likelihood\" of needing to adjust their products to protect against the Omicron variant, the World Health Organization's (WHO) spokesperson said on Friday.</p>\n<p>Christian Lindmeier, speaking at a U.N. briefing in Geneva, said the agency was studying the transmissibility and severity of the variant first detected in southern Africa last month.</p>\n<p>\"It is very recommendable that vaccine manufacturers already start planning ahead and plan for the likelihood for having to adjust the existing vaccine,\" he said.</p>\n<p>\"That's good not just to wait until the final alarm bell rings,\" he said.</p>\n<p>Germany's BioNTech&nbsp;should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, its CEO Ugur Sahin told the Reuters Next conference on Friday.</p>\n<p>South African scientists studying the Omicron outbreak believe symptoms are less severe for those reinfected with COVID-19 by the new variant or infected after vaccination, a top scientist said on Thursday.</p>\n<p>Maria van Kerkhove, the WHO's technical lead on COVID-19, said on Wednesday that the body expected to have more information on the transmissibility of the new Omicron variant \"within days\".</p>\n<p>\"It will still take some time and let's not rush into conclusions here,\" Lindmeier said on Friday.</p>\n<p>\"Preliminary data, and we have said that now since awhile, show that there is higher transmissibility. But that's all that we basically have so far,\" he said.</p>\n<p>Delta remains the dominant variant globally, accounting for more than 90% of infections, Lindmeier said.</p>\n<p>\"So Omicron may be on the rise, and we may come to point where it takes over to be the dominant variant, but at this point the very dominant variant remains Delta,\" he said.</p>\n<p>\"The restrictions that were put into place in many countries just two weeks ago, economic closures again, lockdowns in some areas, closure of Christmas markets in parts of Europe, this was done before Omicron because of a rise in Delta cases.</p>\n<p>Let's not lose sight of this,\" he added.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康","MRNA":"Moderna, Inc.","LLY":"礼来","MRK":"默沙东","SNY":"赛诺菲安万特","BNTX":"BioNTech SE","JNJ":"强生","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177709350","content_text":"GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the \"likelihood\" of needing to adjust their products to protect against the Omicron variant, the World Health Organization's (WHO) spokesperson said on Friday.\nChristian Lindmeier, speaking at a U.N. briefing in Geneva, said the agency was studying the transmissibility and severity of the variant first detected in southern Africa last month.\n\"It is very recommendable that vaccine manufacturers already start planning ahead and plan for the likelihood for having to adjust the existing vaccine,\" he said.\n\"That's good not just to wait until the final alarm bell rings,\" he said.\nGermany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, its CEO Ugur Sahin told the Reuters Next conference on Friday.\nSouth African scientists studying the Omicron outbreak believe symptoms are less severe for those reinfected with COVID-19 by the new variant or infected after vaccination, a top scientist said on Thursday.\nMaria van Kerkhove, the WHO's technical lead on COVID-19, said on Wednesday that the body expected to have more information on the transmissibility of the new Omicron variant \"within days\".\n\"It will still take some time and let's not rush into conclusions here,\" Lindmeier said on Friday.\n\"Preliminary data, and we have said that now since awhile, show that there is higher transmissibility. But that's all that we basically have so far,\" he said.\nDelta remains the dominant variant globally, accounting for more than 90% of infections, Lindmeier said.\n\"So Omicron may be on the rise, and we may come to point where it takes over to be the dominant variant, but at this point the very dominant variant remains Delta,\" he said.\n\"The restrictions that were put into place in many countries just two weeks ago, economic closures again, lockdowns in some areas, closure of Christmas markets in parts of Europe, this was done before Omicron because of a rise in Delta cases.\nLet's not lose sight of this,\" he added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":809,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":11,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Vaccine makers should plan to adjust COVID-19 jabs - WHO

评论（1）

热议股票